Published: 1st Dec, 2023
Context:
These indigenous products will lead to drug prices being slashed up to 100 times of their current market value.
Four Rare Diseases:
- The Union Health Ministry has made available generic drugs to support the care and treatment of four ailments:
- Tyrosinemia-Type 1
- Gauchers Disease
- Wilson’s Disease
- The Dravet-Lennox Gastaut Syndrome
The cost of these drugs will be slashed by anywhere between 60 and 100 times of their current market value.
Other Rare Diseases:
- The Ministry is also in the process of making available drugs for more rare diseases, including Phenylketonuria and Hyperammonemia.
|
Rare Disease:
|
Priority diseases:
- Thirteen rare diseases were prioritized like sickle cell anemia for children.
- This venture is purely a non-commercial venture guided only with the motive to serve those in acute need.
- For years, the Health Ministry through various schemes has been trying to financially help as many patients as possible but this is a more sustainable measure for not just patients in India but also worldwide.
- Several companies -- including Biophore India, Laurus Labs, Azico Biophore, MSN Pharmaceuticals, Akums Drugs and Pharmaceutical – have come forward to take part in the venture.
Courses
Study
Notes
Home
Resources
More
